Stemcell101.com
  • Home
  • About Us
    • About Us
    • Causes We Support
  • Stem Cell Info
    • Stem Cell Research
    • Stem Cell Applications
    • Health and Beauty
    • Pets / Animals
    • Nutrition
    • Stem Cell Blogs
    • A Stem Cell Story
  • Health Care Directory
  • Contact Us
Select Page

Bluebird Bio sickle cell gene therapy trial halted on cancer worry

by rss feed | Feb 16, 2021 | biotechs, Bluebird Bio, gene therapy, News Feeds, Sickle Cell Disease

Recently I was going through a list I’m updating of regenerative medicine biotech companies including Bluebird Bio. Now just a few days later the world seems turned upside down for the firm and maybe to some degree for other companies doing related work....

Recommended reads: CRISPR for Sickle Cell, Parkinson’s, & more

by rss feed | Jan 17, 2021 | CRISPR, CRISPR sickle cell, News Feeds, Parkinson's Disease, Sickle Cell Disease, Weekend Reads, weekly reads

I’m playing catch-up on some reading given how busy I’ve been and this includes a groundbreaking NEJM pub on CRISPR for Sickle Cell and Thalassemia. CRISPR for Sickle Cell From December, here’s the key paper in the NEJM: CRISPR-Cas9 Gene Editing for...

Recommended reads: CRISPR for Sickle Cell, Parkinson’s, & more

by rss feed | Jan 17, 2021 | CRISPR, CRISPR sickle cell, News Feeds, Parkinson's Disease, Sickle Cell Disease, Weekend Reads, weekly reads

I’m playing catch-up on some reading given how busy I’ve been and this includes a groundbreaking NEJM pub on CRISPR for Sickle Cell and Thalassemia. CRISPR for Sickle Cell From December, here’s the key paper in the NEJM: CRISPR-Cas9 Gene Editing for...

Quick Navigation

  • Home
  • Stem Cell Info
    • Stem Cell Research
    • Stem Cell Applications
    • Health and Beauty
    • Pets / Animals
    • Nutrition
    • Stem Cell Blogs
    • A Stem Cell Story
  • Health Care Directory
  • Contact Us
  • About Us
    • About Us
    • Causes We Support

RSS Recent Post

Sign up for StemCell101.com Mailing List

By subscribing to our mailing list, you will get the latest news from us.